AACC Meeting Focuses on FDA Approval Process, Strategies to Bring Proteomics Dxs to Market

At last week's meeting, a speaker also told proteomics researchers to embrace private industry and called for changes in the patent system in order to hasten protein-based diagnostics to market.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.